August 14, 2019 / 11:31 PM / a month ago

Judge certifies Niaspan 'pay-for-delay' class action against AbbVie, Teva

A federal judge on Wednesday certified a class of drug purchasers suing AbbVie Inc and Teva Pharmaceutical Industries Ltd over an alleged anticompetitive agreement that delayed the release of a generic version of the cholesterol drug Niaspan.

U.S. District Judge Jan DuBois in Philadelphia rejected arguments by AbbVie and Teva that the direct purchasers -primarily drug wholesale distributors - should be required to litigate their cases on an individual basis.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below